Note: Ingredients listed on restricted chemical lists
EC/CAS
247-500-7/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0,0015
EC/CAS
220-239-6
Name of the chemical
Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one 2-Methyl-2H-isothiazol-3-one
Concentration
N/A
General Information
Version
1.0
Revision date
2024-11-21
Product name
HYGEL LV40
Manufacturer Name
C/Plató
Emergency telephone
+34 93 849 6188
Icons in SDS
Company Information
company name
DERYPOL, S.A HQ
e-mail address of the competent person responsible for the Safety Data Sheet
regulatory@derypol.com
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Contains
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7], and 2-methyl- 2H -isothiazol-3-one [EC no. 220-239-6] (3:1)
Supplemental label elements
EUH210 - Safety data sheet available on request.
2.3 Other hazards
This substance/mixture does not contain components that are considered to be persistent, bioaccumulative and toxic (PBT) or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7], and 2- accordance with Article 59(1) of REACH for having methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1) (55965-84-9)(¹) endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis
